Disclosure Of Intangible Assets [Text Block]

Xspray Pharma - Filing #679276

Concept As at
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
Disclosure of intangible assets [text block]
*
Research and development expense
40 259 SEK
22 219 SEK
Disclosure of reconciliation of changes in intangible assets and goodwill [text block]
Disclosure of reconciliation of changes in intangible assets and goodwill [abstract]
Disclosure of reconciliation of changes in intangible assets and goodwill [line items]
Reconciliation of changes in intangible assets and goodwill [abstract]
Intangible assets and goodwill
436 780 SEK
385 597 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.